Merck's earnings call highlights strong performance despite a challenging economic environment.  The merger integration is progressing, and management emphasizes investments in growth areas and the company's long-term pipeline.  While patent expirations for some key products pose a short-term concern, the focus on new product launches and potential synergies suggests a positive outlook in the near term, but the market will likely wait for full Q1 2010 guidance.
[1]
